Increasing fetal hemoglobin in sickle cell disease: comparisons of 5-azacytidine (subcutaneous or oral) with hydroxyurea.
D000328:Adult; D000755:Anemia, Sickle Cell / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D001374:Azacitidine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D005319:Fetal Hemoglobin / Q000096:biosynthesis*; D006801:Humans; D006918:Hydroxyurea / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D012156:Reticulocytes / Q000187:drug effects
D005319:Fetal Hemoglobin; D001374:Azacitidine; D006918:Hydroxyurea